Director:
Ahmed Samy ; until 05 November 2018; Umberto La Magna ; until 19 November 2017; Gavin Scott Morant Smith ; until 16 May 2017; Maha Mostafa Ahmed Shafik ; until 18 June 2017; Jason Smith ; until 28 February 2018; Ramsey Morad ; until 27 May 2020
Shareholder:
Allergan Holdings Limited
Update Time:
2020-09-24
Remark:
{"Trading Name": "Allergan Middle East", "Business activities": "Management Consultancies; Managing Office", "Type of License": "Non Regulated", "Type of Entity": "Private Company", "DNFBP": " Designated Non-Financial Businesses and Professions ; No", "Commercial License Validity Date": "2021-02-26", "Financial Year End": "31st December", "Class of Issued Shares": "A", "Data Controller": "Allergan Middle East Ltd.", "Permits required by Data Controller": "", "Notification of Personal Data operations": "No", "Permit to transfer Personal Data": "No", "Permit to Process Sensitive Personal Data": "No"}